Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

79.31USD
11:55am EDT
Change (% chg)

$0.94 (+1.20%)
Prev Close
$78.37
Open
$78.71
Day's High
$79.59
Day's Low
$76.30
Volume
137,976
Avg. Vol
539,661
52-wk High
$151.67
52-wk Low
$62.22

Davis, G. Eric 

Mr. G. Eric Davis serves as Executive Vice President, General Counsel and Secretary of Biomarin Pharmaceutical Inc. From December 2005 to March 2016, Mr. Davis served as our Senior Vice President, General Counsel and Secretary and from 2004 to December 2005, Mr. Davis served as our Vice President, General Counsel and Secretary. From 2000 to 2004, Mr. Davis worked in the San Francisco office of Paul Hastings LLP (formerly Paul, Hastings, Janofsky & Walker LLP), where he served on the firm’s national securities practice committee. Mr. Davis has represented public and private companies and venture capital and investment banking firms in a wide range of corporate and securities matters, mergers and acquisitions, strategic alliance matters, and intellectual property-related business transactions. His experience involves a variety of industries, including biotechnology and life sciences. Mr. Davis received a B.A. in political economy from the University of California, Berkeley, and a J.D. from the University of San Francisco School of Law.

Basic Compensation

Total Annual Compensation, USD 409,593
Restricted Stock Awards, USD 569,604
Long-Term Incentive Plans, USD --
All Other, USD 1,729,010
Fiscal Year Total, USD 2,708,210

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 37,854 1,773,060.00
Name Fiscal Year Total

Jean-Jacques Bienaime

13,636,600

Daniel Spiegelman

3,862,060

G. Eric Davis

2,708,210

Jeff Ajer

3,756,680

Robert Baffi

3,763,880

Henry Fuchs

4,775,290
As Of  30 Dec 2015